KINTOR’S GT20029 PHASE 2 TRIAL RESULTS April 27, 2024 KINTOR’S GT20029 PHASE 2 TRIAL RESULTS Read More »
KX-826 AND GT20029 UPDATES FROM KINTOR PHARMA’S PHASE 3 TRIAL November 29, 2023 KX-826 AND GT20029 UPDATES FROM KINTOR PHARMA’S PHASE 3 TRIAL Read More »
GT20029 PERFORMS WELL IN PHASE 1 TRIALS FOR ANDROGENETIC ALOPECIA October 20, 2023 GT20029 PERFORMS WELL IN PHASE 1 TRIALS FOR ANDROGENETIC ALOPECIA Read More »
